New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2

Daniel J. Drucker, Julie Lovshin, Laurie Baggio, Min Nian, Feisal Adatia, Robin P. Boushey, Yuanfang Liu, Jumana Saleh, Bernardo Yusta, Louise Scrocchi

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Glucagon-like peptides 1 and 2 (GLP-1 and GLP-2) are coencoded within a single mammalian proglucagon precursor, and are liberated in the intestine and brain. GLP-1 exerts well known actions on islet hormone secretion, gastric emptying, and food intake. Recent studies suggest GLP-1 plays a central role in the development and organization of islet cells. GLP-1 receptor signaling appears essential for β cell signal transduction as exemplified by studies of GLP-1R-/- mice. GLP-2 promotes energy assimilation via trophic effects on the intestinal mucosa of the small and large bowel epithelium via a recently cloned GLP-2 receptor. The actions of GLP-2 are preserved in the setting of small and large bowel injury and inflammation. The biological actions of the glucagon-like peptides suggest they may have therapeutic efficacy in diabetes (GLP-1) or intestinal disorders (GLP-2).

Original languageEnglish
Pages (from-to)226-232
Number of pages7
JournalAnnals of the New York Academy of Sciences
Volume921
Publication statusPublished - 2000

Fingerprint

Glucagon-Like Peptides
Glucagon-Like Peptide 1
Glucagon-Like Peptide 2
Proglucagon
Signal transduction
Gastric Emptying
Intestinal Mucosa
Medical problems
Islets of Langerhans
Intestines
Signal Transduction
Brain
Epithelium
Eating
Hormones
Inflammation
Wounds and Injuries
Cells

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Drucker, D. J., Lovshin, J., Baggio, L., Nian, M., Adatia, F., Boushey, R. P., ... Scrocchi, L. (2000). New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2. Annals of the New York Academy of Sciences, 921, 226-232.

New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2. / Drucker, Daniel J.; Lovshin, Julie; Baggio, Laurie; Nian, Min; Adatia, Feisal; Boushey, Robin P.; Liu, Yuanfang; Saleh, Jumana; Yusta, Bernardo; Scrocchi, Louise.

In: Annals of the New York Academy of Sciences, Vol. 921, 2000, p. 226-232.

Research output: Contribution to journalArticle

Drucker, DJ, Lovshin, J, Baggio, L, Nian, M, Adatia, F, Boushey, RP, Liu, Y, Saleh, J, Yusta, B & Scrocchi, L 2000, 'New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2', Annals of the New York Academy of Sciences, vol. 921, pp. 226-232.
Drucker DJ, Lovshin J, Baggio L, Nian M, Adatia F, Boushey RP et al. New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2. Annals of the New York Academy of Sciences. 2000;921:226-232.
Drucker, Daniel J. ; Lovshin, Julie ; Baggio, Laurie ; Nian, Min ; Adatia, Feisal ; Boushey, Robin P. ; Liu, Yuanfang ; Saleh, Jumana ; Yusta, Bernardo ; Scrocchi, Louise. / New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2. In: Annals of the New York Academy of Sciences. 2000 ; Vol. 921. pp. 226-232.
@article{d600f9571eb048aba73259042a87c5b1,
title = "New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2",
abstract = "Glucagon-like peptides 1 and 2 (GLP-1 and GLP-2) are coencoded within a single mammalian proglucagon precursor, and are liberated in the intestine and brain. GLP-1 exerts well known actions on islet hormone secretion, gastric emptying, and food intake. Recent studies suggest GLP-1 plays a central role in the development and organization of islet cells. GLP-1 receptor signaling appears essential for β cell signal transduction as exemplified by studies of GLP-1R-/- mice. GLP-2 promotes energy assimilation via trophic effects on the intestinal mucosa of the small and large bowel epithelium via a recently cloned GLP-2 receptor. The actions of GLP-2 are preserved in the setting of small and large bowel injury and inflammation. The biological actions of the glucagon-like peptides suggest they may have therapeutic efficacy in diabetes (GLP-1) or intestinal disorders (GLP-2).",
author = "Drucker, {Daniel J.} and Julie Lovshin and Laurie Baggio and Min Nian and Feisal Adatia and Boushey, {Robin P.} and Yuanfang Liu and Jumana Saleh and Bernardo Yusta and Louise Scrocchi",
year = "2000",
language = "English",
volume = "921",
pages = "226--232",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2

AU - Drucker, Daniel J.

AU - Lovshin, Julie

AU - Baggio, Laurie

AU - Nian, Min

AU - Adatia, Feisal

AU - Boushey, Robin P.

AU - Liu, Yuanfang

AU - Saleh, Jumana

AU - Yusta, Bernardo

AU - Scrocchi, Louise

PY - 2000

Y1 - 2000

N2 - Glucagon-like peptides 1 and 2 (GLP-1 and GLP-2) are coencoded within a single mammalian proglucagon precursor, and are liberated in the intestine and brain. GLP-1 exerts well known actions on islet hormone secretion, gastric emptying, and food intake. Recent studies suggest GLP-1 plays a central role in the development and organization of islet cells. GLP-1 receptor signaling appears essential for β cell signal transduction as exemplified by studies of GLP-1R-/- mice. GLP-2 promotes energy assimilation via trophic effects on the intestinal mucosa of the small and large bowel epithelium via a recently cloned GLP-2 receptor. The actions of GLP-2 are preserved in the setting of small and large bowel injury and inflammation. The biological actions of the glucagon-like peptides suggest they may have therapeutic efficacy in diabetes (GLP-1) or intestinal disorders (GLP-2).

AB - Glucagon-like peptides 1 and 2 (GLP-1 and GLP-2) are coencoded within a single mammalian proglucagon precursor, and are liberated in the intestine and brain. GLP-1 exerts well known actions on islet hormone secretion, gastric emptying, and food intake. Recent studies suggest GLP-1 plays a central role in the development and organization of islet cells. GLP-1 receptor signaling appears essential for β cell signal transduction as exemplified by studies of GLP-1R-/- mice. GLP-2 promotes energy assimilation via trophic effects on the intestinal mucosa of the small and large bowel epithelium via a recently cloned GLP-2 receptor. The actions of GLP-2 are preserved in the setting of small and large bowel injury and inflammation. The biological actions of the glucagon-like peptides suggest they may have therapeutic efficacy in diabetes (GLP-1) or intestinal disorders (GLP-2).

UR - http://www.scopus.com/inward/record.url?scp=0034511625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034511625&partnerID=8YFLogxK

M3 - Article

C2 - 11193827

AN - SCOPUS:0034511625

VL - 921

SP - 226

EP - 232

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -